Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pangenomic Health Inc C.NARA

Pangenomic Health Inc. is a precision health company. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support... see more

Recent & Breaking News (CSE:NARA)

Mydecine closes sale of subsidiary, Mindleap Health, to PanGenomic Health (CSE:NARA)

Azuka Onwuka December 12, 2022

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.

GlobeNewswire December 12, 2022

PanGenomic Health Completes Acquisition of Mindleap Health

Canada NewsWire December 12, 2022

PanGenomic Health Enters into Definitive Agreement for Acquisition of Mindleap Health

Canada NewsWire November 21, 2022

PanGenomic Health Appoints Maryam Marissen as CEO

Canada NewsWire September 6, 2022

PanGenomic Health Inc Signs a Non-binding Letter of Intent for the Acquisition of Mindleap Health Inc.

Canada NewsWire September 1, 2022

IIROC Trade Resumption - NARA

Canada NewsWire September 1, 2022

IIROC Trading Halt - NARA

Canada NewsWire September 1, 2022

Mydecine Innovations Group Signs a Letter of Intent to Sell its Wholly-Owned Subsidiary, Mindleap Health Inc.

GlobeNewswire September 1, 2022

Canadian Securities Exchange Reports July 2022 Performance Figures

Newsfile August 16, 2022

Natural Remedy App Launched to Support Mental Health

Canada NewsWire August 3, 2022

PanGenomic Health engages Investor Relations Services Provider, Meus Management, and Market Maker Services Provider, Generation IACP

Canada NewsWire July 20, 2022

PanGenomic Health Commences Trading on the CSE Under the Symbol "NARA" and Release of Escrowed Proceeds

Canada NewsWire July 18, 2022